London researchers look to cannabis to treat common side effects of Alzheimer’s disease

The Institute of Psychiatry, Psychology, & Neuroscience at King’s College London is currently studying the potential role cannabis can play in treating common side effects, like dementia, from patients suffering from Alzheimer’s disease.

Chris Albertyn, Research Portfolio Lead at the Institute, joins the Vault to reveal the study’s most recent results.

Listen to the full episode below:

 

John Kuster

As Social Media Coordinator, John oversees all things related to getting Revolution Enterprises' unique message out. An Iowa native, John joined the Revolution team to help educate, and inform the public on cannabis and all it has to offer. Prior to joining Revolution, John helped multiple companies grow and expand their reach, ranging from the tech industry to the world of international football. He is thrilled to be working in a rapidly expanding market, and is proud to represent Illinois patients and cannabis advocates across the globe.